Background: Assessment of volume state is difficult in hemodialysis patients. Whether continuous blood volume monitoring can improve the assessment of volume state is unclear.
O
ptimization of volume is a key component of the management of hemodialysis patients 1 and was the subject of numerous investigations. [2] [3] [4] [5] [6] Assessment of volume state in these patients is central to prescribing volume removal, and volume control is believed to be important to judge the adequacy of hemodialysis. 7 An accurate prescription can improve tolerance and adherence to dialysis therapy and avoid the long-term consequences of volume excess. 8 Clinical experience suggests that keeping the patient "too wet" may lead to poor long-term outcomes, and "too dry," to poor tolerance. A fluid removal rate that exceeds the refilling rate of the intravascular volume may result in hypotension, which continues to be a vexing problem for which new therapies are being developed.
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Importantly, dialysis-related hypotension is associated with increased mortality. 12, 13 However, inadequate removal of fluid may lead to a longterm increase in cardiac output, compensatory increase in systemic vascular resistance, and hypertension. 8, 14, 15 In turn, this can lead to cardiovascular morbidity and mortality. 16 Epidemiological studies suggested that expanded extracellular fluid volume in hemodialysis patients was associated with increased all-cause mortality. 17, 18 Intradialytic blood volume monitoring (IBVM) is a commercially available technology that can measure relative blood volume (RBV) changes during hemodialysis. [19] [20] [21] One such instrument for IBVM uses photo-optical technology to noninvasively measure absolute hematocrit and percentage of blood volume change in real time. 21 The slopes of RBV displayed on the screen indicate the rate of RBV decrease and have largely been were used to gauge hemodynamic stability during dialysis, with mixed success. [22] [23] [24] Although IBVM can be performed safely and inexpensively and has the potential to improve volume control, 25, 26 no normative data are available; thus, the optimal level of fluid removal guided by blood volume monitoring is unknown. 27 The purpose of this study is to develop a better marker of volume in hemodialysis patients. Accordingly, we compared 3 markers of volume excess with outcome parameters that included intradialytic signs and symptoms of hypotension and interventions and echocardiographically assessed blood volume. The 3 markers of volume were ultrafiltration rate (UFR) indexed for body weight, which we call UFR index; RBV slope; and RBV slope adjusted for UFR index, which we call volume index. We designed this study to assess the interrelationships between IBVM intradialytic symptoms and markers of excess volume on echocardiograms.
METHODS

Conceptual Model
To conceptualize volume compartments, we formulated a model to review the physiological characteristics of volume removal during hemodialysis (see Appendix for details and Table 1 for outline). The amount of ultrafiltration prescribed dictates the stress placed on intravascular volume. More accurately, it is not ultrafiltration by itself, but UFR corrected for body weight (a reflection of total-body water) that produces the volume stress. We call this the ultrafiltration index. In response to the UFR index, hematocrit change in the intravascular compartment and the magnitude of this is measured by means of RBV slope. RBV slope is a function of fluid removal rate (UFR index) and plasma refill rate. Adjustment of RBV slope for UFR index would be an index of the plasma refill rate. Because UFR index is known for each patient, RBV slope corrected for UFR index, the volume index, is simply a reflection of the latent volume pool and the ability of this pool to replenish the intravascular compartment. Using this model, it is possible to define the volume marker being tested. Table 1 lists the 3 indices.
Definitions of Volume Markers
UFR Index
Total amount of ultrafiltration (milliliters) was calculated for each patient based on the dialysis machine reading. Total volume of ultrafiltration was divided by dialysis time in hours to calculate UFR. UFR divided by postdialysis weight (kilograms) provided UFR index. UFR index ϭ ultrafiltration (mL)/dialysis time (h)/postdialysis weight (kg).
RBV Slope
The slope of RBV over time was calculated as percentage per hour by using a straight-line change model, described in the data analysis section.
Volume Index
RBV slope was adjusted for UFR index to provide volume index. This parameter, as discussed, is suggested to be a marker of vascular refilling rate.
Subjects
This is a cross-sectional study performed at 4 dialysis units in Indianapolis affiliated with Indiana University during 2 consecutive weeks. One unit was at the Veterans Administration (VA) Hospital, but the other 3 were VAunaffiliated units. Patients 18 years or older who had been on long-term hemodialysis therapy for more than 3 months and were free of vascular, infectious, or bleeding complication within 1 month were enrolled in the study. Those who missed 2 or more hemodialysis treatments during 1 month, Anthropometric and demographic characteristics were recorded. Echocardiography was performed by 1 echocardiographer immediately after the termination of dialysis within an hour of the end of dialysis treatment.
A total of 150 long-term hemodialysis patients were recruited between September 2003 and February 2005. The sample was drawn from 355 patients on thrice-weekly hemodialysis therapy from 4 dialysis units affiliated with Indiana University, of which 48% were women, 36% had diabetes, and 72% were black. Because fewer white patients were recruited, the racial make-up of the 126 patients who were screened, but did not participate, were analyzed. Of these, 41 blacks (76%), 12 (22%) whites, and 1 (2%) Asian met the recruitment criteria, but refused participation. Fiftyfive blacks (76%), 15 whites (21%), and 2 Asians (3%) did not meet 1 of the inclusion or exclusion criteria. Because 27 of 126 (21%) did not meet eligibility or refused participation, our sample included more black participants than the overall composition from which the sample was derived.
The study was approved by the Institutional Review Board of Indiana University and Research and Development Committee of the Roudebush VA Medical Center, Indianapolis, and all subjects gave written informed consent.
Predictors
Intradialytic Blood Volume Monitoring
All 150 patients underwent successful IBVM, which was performed once during the 2-week period. Crit-Line III-TQA (Hemametrics, Salt Lake City, UT) is a fluidmanagement and access-monitoring tool approved by the Food and Drug Administration. It incorporates photooptical technology to noninvasively measure absolute hematocrit, percentage of blood volume change, and continuous oxygen saturation. 21 An autoscaling screen Note: Values expressed as mean Ϯ SD or number (percent). To convert albumin in g/dL to g/L, multiply by 10; hemoglobin in g/dL to g/L multiply by 10. displays simultaneous graphic output of blood volume change versus time, as well as alphanumeric output of hematocrit. Measurements are made every 20 seconds throughout the duration of the hemodialysis treatment. Hematocrit measurements made by the machine were validated against hematocrits measured by using centrifugation. 20 We exported the machine-stored time and hematocrit data to a relational database for further analysis. To analyze the rebound in RBV, we turned ultrafiltration off 15 minutes before the end of dialysis.
Outcomes
Assessment of Intradialytic Hypotension
During 2 consecutive weeks, each hemodialysis patient participating in the study was prospectively questioned by research technicians regarding the presence or absence of various intradialytic symptoms, such as cramps, dizziness, nausea, and headache. Symptoms of hypotension, such as cramps and dizziness, were obtained from patients at the end of each dialysis treatment. Data were collected on structured case report forms. In addition, episodes of dialysis in which Figure 1 . The volume index: relationship of relative blood volume (RBV) slopes as a function of ultrafiltration (UF) rate (UFR) index in different patients. Top line, 10th percentile; middle line, 50th percentile; and bottom line, 90th percentile. RBV slopes increase in steepness from the 10th to 90th percentile. (Right) The relationship of RBV slope rebound in the last 15 minutes of dialysis when UF is stopped. For patients in the 90th percentile, the intercept is lower and rebound is steeper. For patients in the 10th percentile, the intercept is higher and rebound is less steep. systolic blood pressure decreased to less than 100 mm Hg were recorded. Interventions, such as decreasing UFR, stopping ultrafiltration, need for saline, placement in Trendelenberg position, or early termination of dialysis, were also noted.
Echocardiograms
Two-dimensional guided M-mode echocardiograms were obtained immediately after a midweek hemodialysis session by using a digital cardiac ultrasound machine (Cypress Acuson; Siemens Medical, Malvern, PA). The postdialysis period was selected for echocardiography because it allows control over the volume state of the patient because it is associated with the least intravascular volume. The day after dialysis would be associated with a variable change in the dimension of the ventricular cavity, depending on the state of volume expansion, and was not chosen for echocardiography. Inferior vena cava (IVC) diameter was measured at the level just below the diaphragm in the hepatic segment by using 2-dimensional guided M-mode echocardiography. IVC diameter was measured just before the P wave of the electrocardiogram during end-expiration and end-inspiration while avoiding Valsalva-like maneuvers. Collapsibility index was defined as: (maximal diameter on expiration Ϫ minimal diameter on deep inspiration)/maximal diameter on expiration ϫ 100. 28 All measurements represent an average of 6 consecutive cardiac cycles. Although criteria were developed to detect volume overload and volume depletion, it is unknown whether these thresholds would be valid for postdialysis state.
28 Therefore, tertiles of these measurements were used to define relative volume excess, relative euvolemia, and relative volume depletion. Echocardiograms were either not obtained or IVC measurements were technically challenging in 15 patients. Accordingly, data for echocardiograms represent only 135 patients.
Data Analysis
In hemodialysis patients, fluid removal results in hemoconcentration. Continuous measurement of hematocrit every 20 seconds allows estimation of fractional change in RBV. RBV was calculated as initial hematocrit divided by instantaneous hematocrit. We transformed the time variable to hours to provide a more meaningful metric of change in RBV such that change was calculated per hour instead of per second.
To test the association of hemodynamic instability and its treatment with UFR index, RBV, or volume index, we counted the number of dialysis treatments during 2 weeks in which the patient experienced cramps; nausea; headache; hypotension, defined as systolic blood pressure less than 100 mm Hg; or dizziness. We also counted the number of dialysis treatments in which the patient was placed in Trendelenberg position or had ultrafiltration reduced, ultrafiltration discontinued, saline administered, or dialysis terminated early. We used a logistic regression model along with generalized estimating equations for comparing clinical symptoms data collected at these 6 visits with UFR index, RBV, and volume index. This method takes into account correlations among repeated measurements. 29 Each result is a separate regression model not adjusted for demographic or clinical characteristics.
Tertiles of IVC diameter were created. The middle tertile (IVC diameter, 6.73 to 9.3 mm/m 2 ) defined relative euvolemia. The lower tertile (IVC diameter Ͻ 6.73 mm/m 2 ) was used to define volume depletion, and the upper tertile (IVC diameter Ͼ 9.3 mm/m 2 ), volume excess. IVC collapse index in the middle tertile (21.63% to 40.23%) defined relative euvolemia. The upper tertile (collapse index Ͼ 40.23%) was used to define volume depletion, and the lower tertile (collapse index Ͻ 21.63%), volume excess. Sensitivity and specificity of the 3 markers of volume were calculated for various cutoff values to generate receiver operating characteristic (ROC) curves, including area under the curve and their 95% confidence intervals (CIs). In an additional analysis, we classified patients to have volume excess if they had volume excess by means of both IVC diameter and collapse criteria, and volume depletion, if they had volume depletion by means of both criteria. ROC curves were also fit for the combined criteria. The ROC curve for UFR index was compared with the ROC curve for RBV and volume index, and reported P were Bonferroni corrected.
All analyses were conducted using SPSS software, version 14.0 (SPSS Inc, Chicago, IL) and Stata 9.0 (Stata Corp, College Station, TX). The reported P are 2 sided and taken to be significant at less than 0.05. Table 2 . Ninety percent of participants were black, with cardiovascular disease in approximately half the patients. Average Kt/V, serum albumin level, and hemoglobin level reflect the general hemodialysis population. Diabetes mellitus was the cause of endstage renal disease in 31% of patients, and hypertension, in 56%. Appendix. The RBV slope model (model 2) shows that the intercept was close to 100%, as expected, and mean slope was Ϫ2.32%/h. The volume index model (model 6) shows improved model fit over the RBV model. RBV slope was Ϫ0.255%/h/mL/h ultrafiltration /kg postdialysis weight. Figure 1 shows the relationship of RBV slopes at different levels of UFR index. The top line represents the 10th percentile of UFR index (3.29 mL/h/kg); the middle, the 50th percentile of UFR index (8.13 mL/h/kg); and the bottom, the 90th percentile of UFR index (13.34 mL/h/ kg). RBV slopes increase in steepness from the 10th to 90th percentile. The relationship of RBV slope rebound in the last 15 minutes of dialysis when ultrafiltration is stopped is shown in the right panel. These rebound data were available for only 105 patients. The top line represents the 10th percentile; the middle, the 50th percentile; and the bottom, the 90th percentile of UFR index. For patients in the 90th percentile, the intercept is lower and the rebound is steeper. For patients in the 10th percentile, the intercept is higher and the rebound is less steep. Volume index rebound was 0.558%/h (95% CI, 0.262 to 0.853; P Ͻ 0.001). Table 3 lists the 2-week prevalence of symptoms of hypotension and interventions. Cramps were the most common symptom, followed by dizziness, nausea, and headache. Hypotension, symptomatic or not, was experienced by 47% of participants. Ultrafiltration needed to be stopped in 45% of participants, and placement in Trendelenberg position was required in 3%. Cramps complicated 19% of dialysis treatments, and placement in Trendelenberg position, only less than 1%. The percentage of dialysis sessions complicated by events was remarkably similar across symptoms and interventions for hypotension-related symptoms, which varied from 22% to 43%. Intraclass correlation coefficients were all greater than zero, indicating a propensity to have events within individuals. Table 4 lists relationships among dialysisrelated hypotension, its symptoms, and interventions. These interventions represent what occurred during 6 dialysis treatments, not the one associated with RBV monitoring alone. The odds of having hypotension-related symptoms or interventions did not depend on UFR indices. RBV slopes had marginal significance for multiple parameters, but achieved statistical significance for only early termination of hemodialysis. Conversely, volume index was significant for 3 signs and symptoms or intervention.
RESULTS
Between
Indices of Volume Changes
Relationship Between Symptoms/ Interventions and Markers of Volume
Relationship Between Echocardiographic Findings and Markers of Volume
IVC end-expiration diameter averaged 8.7 Ϯ 3.7 (SD) mm, and IVC collapse index was 31.1% Ϯ 17.9%. Table 5 lists bivariate relationships between volume indices and echocardiographic markers of volume. UFR index was not predictive of volume markers. RBV and volume index significantly predicted both IVC endexpiration diameter and collapse index. Figure 2 shows ROC curves for the diagnosis of volume overload (left panel) or volume depletion (right panel). UFR index was not able to discriminate volume overload by using IVC collapsibility index. Conversely, RBV slope and volume index were both able to detect volume overload. Nonetheless, volume index, not RBV slope model, was significantly superior to UFR index. UFR index was not able to detect volume overload by using IVC end-expiration diameter, but both RBV slope and volume index were significant in detecting volume overload.
Volume overload was diagnosed by using combined criteria of IVC end-expiration and IVC collapsibility index in 18% of patients. Using the combined criteria, both RBV and volume index 4 ™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™ were of diagnostic significance. However, only volume index was statistically superior to UFR index. Volume index flatter than 0.221 was 76% sensitive and 70% specific in diagnosing volume overload. None of the indices was very effective in diagnosing volume depletion (right panel , Fig 2) .
DISCUSSION
The major findings of our study are that RBV slope corrected for UFR and body weight (ie, the volume index) and RBV slope obtained by means of continuous blood volume monitoring are potential markers of the volume state. The volume index and RBV slopes are markers of dialysis signs, symptoms, and interventions. Both indices, volume index and RBV slopes, were markers of echocardiographic volume overload, but not volume depletion.
Continuous blood volume monitoring has received considerable attention as a marker of volume state. For example, Mitra et al 30 proposed that departure of RBV slope from linearity correlated with departure from dry weight. Although these data were rigorously analyzed, application of these results is difficult at the bedside. Furthermore, no information was derived from these parameters proposed by Mitra et al 30 regarding when the patient was "too dry." In consideration of this, we modeled our data without transformation, such that our data can be used at the patient's bedside. The taxonomy of models shows that ultrafiltration volume, body weight, and duration of dialysis were each important to improve the model fit (Table 6 ). RBV slopes corrected for UFR index (UFR divided by postdialysis weight) provided the volume index, which had the best model fit (Table 6 , model 6).
UFR index did not predict any symptom, sign, or hypotension-related intervention. RBV slopes were not predictive of any sign or symptom, but achieved statistical significance for early termination of dialysis treatment. Volume index was predictive of dizziness, placement in Trendelenberg position, and reduction in ultrafiltration. Our data are consistent with previous observations reviewed by Dasselaar et al. 24 Andrulli et al 23 noted that when symptomatic hypotension occurred, RBV reduction was not significantly different from that recorded at the same time during hypotension-free sessions. They found no difference in decreases in RBV in normotensive, hypotension-prone, and hypertensive patients and also no critical RBV level for the appearance of symptomatic hypotension. Whether a better model fit and stronger association of volume index with signs and symptoms will translate into it being a better marker of volume overload and subsequent outcomes will need to be determined in future studies.
Volume index ROC curve had an area under the curve of 0.73. Interpretation of the value of area under the curve of 0.73 is as follows: if 2 hemodialysis patients had IBVM and volume index was used to make a diagnosis of volume overload, using the gold standard of echocardiograms, volume index would be right 73% of the time. The 95% CI indicates that the test will be right 56% to 86% of the time. The likelihood ratio for volume overload when slope was greater than Ϫ0.221%/h/mL/h ultrafiltration /kg was 2.6. This means that patients with slopes flatter than 0.221%/h/mL/h ultrafiltration /kg were 2.6 times as likely to have volume overload compared with those with values less than this threshold. The likelihood ratio of slope steeper than 0.221%/h/ mL/h ultrafiltration /kg was 0.33. This means that patients with slopes steeper than 0.221 were one third as likely to have volume overload compared with those with slopes flatter than 0.221. In other words, the chances of not having volume overload was 3 times as high as having volume overload if volume index slopes were steeper than 0.221.
Taken together, our data suggest that volume index is a marker of latent volume that contributes to plasma refill. It follows that when plasma refill rates are low, volume index becomes steeper, which, if treated with a decrease in ultrafiltration or increase in sodium conductivity, may result in flattening of the volume index. Data accumulated from the use of blood volume tracking technologies show that modulation of ultrafiltration or sodium conductivity can improve hemodynamic stability in comparison to standard dialysis. 31 Similarly, strategies that increase plasma refill, such as use of the colloid hydroxyethylstarch, can restore RBV more effectively than saline.
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Some limitations of our study must be addressed. First, IBVM assumes that uniform mixing of red blood cells occurs throughout the vascular space. However, the distribution of he- 
Note: Because models were nested, comparisons of goodness of fit between models were tested by improvement in the log-likelihood using a chi-square test. All models use RBV as the dependent variable. Independent variables are listed in "Parameter" row. All 150 patients had measurements of RBV and were used in the models.
Abbreviations: RBV, relative blood volume; UFR, ultrafiltration rate; LL, log-likelihood. *P Ͻ 0.001. †P Ͻ 0.01. ‡P Ͻ 0.05.
matocrit in the central circulation and microcirculation may not be constant and may change during episodes of hypotension. 32 Second, clinical and echocardiographic findings are not validated measures of volume. Third, results are not adjusted for demographic or clinical characteristics. Fourth, the majority of patients in our study were black. Whether these data are applicable to nonblacks is uncertain. Accordingly, performance characteristics of the indices may differ across populations. Fifth, although our study provides population parameters of volume index, the optimal volume index associated with the best outcomes is not known. Also, whether the decrease in blood volume with dialysis or rebound of blood volume after dialysis should be used to dictate therapy is unclear. Additional data need to be prospectively gathered that associate clinically relevant outcomes with rates of blood volume decrease with dialysis.
Volume index averaged approximately Ϫ0.25%/ h/mL/h ultrafiltration /kg. Because most patients are dialyzed for 4 hours, it follows that volume change during dialysis would be approximately the UFR index in percent. Thus, a patient with an ultrafiltration volume of 4,000 mL who is dialyzed for 4 hours and weighs 100 kg after dialysis would have a UFR index of 4,000/4/100, or 10 mL/kg/h, and an expected 10% change in RBV during a treatment. If this patient has a 2% change in RBV during 4 hours, it is likely that this patient has volume overload by means of echocardiography and is less likely to experience hypotension-related signs and symptoms. The volume index thus can give a qualitative sense of excess vascular volume in hemodialysis patients.
In a previous randomized controlled trial, IVBM was not useful in guiding volume reduction therapies. 33, 34 In children on hemodialysis therapy, this IVBM led to better outcomes. 35 Perhaps therapy guided by using volume index may serve as a better tool to prescribe sodium reduction therapy in dialysis patients. Volume index appears to be a novel marker of volume, but requires validation studies, and its utility needs to be tested in clinical trials. Future studies should address the impact of this simple index on quality of life and cardiovascular outcomes. the ability of this pool to replenish the intravascular compartment.
Data Analysis
Linear mixed models were used to calculate intercepts and slopes. In this model, the level 1 change describes how each subject changes over time (intraindividual change). More explicitly, a straight-line change model for the individuals was used to model RBV: (1) y it ϭ oi ϩ 1i a it ϩ it (1) where y it is RBV for the ith individual (i ϭ 1, . . . , N) at the tth measurement occasion (t ϭ 1, . . . , T), oi is the intercept for the ith individual, 1i is the slope for the ith individual, a it represents the value of time for the ith individual at the tth measurement occasion, and it is the error for the ith individual at the tth measurement occasion. it was assumed to distribute normally and independently with a mean of zero and constant variance across time. The level 2 model describes how these change coefficients (ie, oi and 1i ) differ across people (interindividual change). The covariates of interest were used to model interindividual differences in intraindividual change. More explicitly, each change coefficient in equation 1 is modeled as a dependent variable in another equation:
where ␤ p0 is the intercept for the pth change parameter (p ϭ 0, 1), ␤ pk is the regression coefficient for the kth covariate, f͑X͒ ki is some function of the X ki (possibly the identify function where no transformation of X occurs), and pi represents the unique effect for the ith individual for the pth change coefficient. Some of the second-level covariates tested were ultrafiltration, duration of dialysis therapy, and postdialysis weight for model development.
To calculate RBV rebound, we log transformed the data before fitting slopes. Results of log transformed and untransformed data were similar before the termination of ultrafiltration. Therefore, we did not use log-transformed RBV results for the majority of the analyses.
We used a taxonomy of models to describe the optimization of the model fit (Table 6) . 36, 37 
